Anthropic’s IPO Meets a Lower Valuation Bar
Anthropic’s planned Nasdaq IPO is entering a tougher valuation debate: CNBC reported that stakeholders now question whether the AI company can support a $1.5 trillion valuation. The shift matters to prospective ANT investors because the central issue is no longer whether Anthropic can reach the $2 trillion valuation it had considered up until recently, but where demand settles below that level.
An IPO valuation is the equity value investors assign to a company when its shares are offered to the public. It establishes the starting expectations embedded in the listing, so a lower figure can make the offering easier to absorb while also signaling that investors have reduced what they are prepared to pay.
The repricing is still an expectation, not a completed transaction. Anthropic’s final IPO valuation, final IPO price and exact listing date are unknown, and the unnamed investors and stakeholders cited in the reporting were not identified.
From $2 Trillion to a Wider Anthropic Valuation Range
CNBC reported that Anthropic was seeking a valuation as high as $2 trillion last month. Stakeholders then said even a $1.5 trillion valuation was in doubt, while one unnamed investor viewed $1 trillion to $1.25 trillion as a more likely target during the latest market turmoil, subject to market conditions.
Those figures frame a widening negotiation rather than a settled price. The $1.5 trillion level sits below the valuation discussed last month, while the unnamed investor’s $1 trillion to $1.25 trillion range sets an even lower expectation. Each remains an estimate until the offering terms establish what investors will accept.
Anthropic was privately valued at $965 billion as of May, according to CNBC. That private benchmark is the clearest confirmed reference point in the supplied record, while every higher figure describes an expectation, reported target or investor view rather than a final public-market outcome.
The distinction is important for interpreting the headline numbers. A private valuation, a valuation sought before an IPO and the valuation ultimately accepted in an offering are separate observations. Comparing them shows how expectations have moved; it does not establish Anthropic’s final market value.
Nasdaq’s Thursday Drop Raises the Execution Test
The Nasdaq declined more than 5% on Thursday, its steepest drop in 19 months, CNBC reported. October was also the Nasdaq’s worst month since March 2025. Together, those market readings define the conditions confronting Anthropic as it prepares to present the offering to investors.
For this IPO, the Nasdaq move is relevant because the unnamed investor explicitly made the $1 trillion to $1.25 trillion valuation view conditional on market conditions. A change in those conditions could therefore alter the range investors consider plausible before pricing, without guaranteeing either a recovery toward prior expectations or a further reduction.
The bearish case is that doubt around $1.5 trillion persists through the marketing process, keeping attention on the lower range cited by the unnamed investor. The counter-scenario is that the roadshow produces sufficient interest to support the low end of previous expectations, the level Gil Luria said investors would anticipate.
Luria, an analyst at D.A. Davidson, argued that pricing the deal well would give Anthropic the best setup for success. His emphasis places execution ahead of the largest headline valuation: the relevant test is whether the chosen terms align with investor demand when the company markets the transaction.
ANT Roadshow: The Next Evidence for Investors
Anthropic is set to list on the Nasdaq under the ticker ANT and was expected to begin its roadshow next week. That process is the next disclosed checkpoint because it will put the company’s valuation expectations in front of prospective investors under the market conditions described in the reporting.
- Track the valuation presented during the roadshow. The key comparison is whether Anthropic continues to pursue $1.5 trillion or moves toward the $1 trillion to $1.25 trillion range cited by the unnamed investor.
- Separate proposed terms from completed pricing. Neither a roadshow target nor an investor estimate establishes the final IPO valuation or final IPO price.
- Monitor Nasdaq conditions. The latest valuation view was expressly subject to market conditions after the index’s more than 5% Thursday decline.
- Wait for listing details. ANT is the planned Nasdaq ticker, while the exact listing date remains unknown.
The decisive evidence will come from the terms Anthropic presents and the valuation ultimately accepted. Until then, the supported conclusion is narrow but directional: expectations have moved below the $2 trillion valuation sought last month, and the roadshow must determine whether even $1.5 trillion remains achievable.
📊 Analysis
Signal Bearish
Why Investor expectations have fallen from the valuation Anthropic sought last month, and even the reduced $1.5 trillion figure is now in doubt.
This article was independently written by OneDayTrading from public reporting. Read the original (CNBC)
